Keith C. Valentine has served as Chief Executive Officer of SeaSpine Holdings, a publicly traded medical device company focused on spinal implants and orthobiologics, since May 2015, and as President since July 2015, and joined their board of directors in July 2015 after a successful spinout from Integra LifeSciences. Prior to joining SeaSpine, Mr. Valentine served as President and Chief Operating Officer of NuVasive, Inc. from January 2007 to January 2015 and as President from December 2004 to January 2007, prior to which he served in various senior executive roles in marketing, development and operations since joining NuVasive in 2001. While at NuVasive, Mr. Valentine was an active supporter of the medical device industry as a board member of the California Healthcare Institute (CHI) and the Medical Device Manufacturers Association (MDMA). Previously, Mr. Valentine served as Vice President of Marketing at ORATEC Interventions, Inc., a medical device company acquired by Smith & Nephew PLC, and spent eight years in various roles with Medtronic Sofamor Danek, including Vice President of Marketing for the Rods Division and Group Director for the BMP Biologics program, the Interbody Sales Development Effort, and International Sales and Marketing. Mr. Valentine currently serves on the board of directors of SI-BONE, Inc., a publicly traded medical device company focused on the treatment of musculoskeletal disorders of the sacro-pelvic anatomy and chairs its nominating and governance committee. Mr. Valentine received a BBA in Management and Biomedical Sciences from Western Michigan University.